STOCK TITAN

DNA (DNA) Form 144 shows director notices to sell 2,200 shares on two dates

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

DNA filing reports notices under Rule 144 to sell Class A shares. The filing lists two reported transactions by Austin Che of 2,200 Class A shares on 01/07/2026 and 02/04/2026, and earlier restricted stock vesting entries dated 10/18/2022 (888 shares) and 10/20/2022 (1,312 shares).

The entries identify Fidelity Brokerage Services LLC and include per-transaction numeric figures (2200) and associated monetary figures shown in the excerpt. This notice-style filing documents planned or reported dispositions; timing and cash-flow treatment are as stated in the entries.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notices record reported dispositions of Class A stock by an associated holder.

These entries show two reported sale notices of 2,200 Class A shares each on 01/07/2026 and 02/04/2026, attributed to Austin Che, and reference prior restricted stock vesting on 10/18/2022 (888 shares) and 10/20/2022 (1,312 shares).

Rule 144 notices are procedural; actual sale settlement, proceeds recipient, and whether transactions were completed are determined by subsequent confirmations and are not detailed further in the excerpt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Ginkgo Bioworks Holdings Inc

NYSE:DNA

View DNA Stock Overview

DNA Rankings

DNA Latest News

DNA Latest SEC Filings

DNA Stock Data

396.32M
59.63M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
BOSTON